Columbus, United States
Redi Health, founded in 2021 and headquartered in the United States, is strategically positioned to transform the patient experience in the pharmaceutical sector. With a compelling slogan, "Leading the Next Generation Patient Experience," the company’s mission is to enhance connections between pharmaceutical manufacturers and patients through innovative technological solutions.
Targeting the B2C, Health Care, and Pharmaceutical industries, Redi Health excels in patient acquisition and medication sustainment, boosting efficiency in enrollment, financial navigation, and therapy adherence. Guiding these efforts are the company's experienced founders who specialize in scaling pharmaceutical-focused solutions.
Recently, Redi Health secured a Series B investment of $14.00 million on 01 February 2024, backed by prominent investors such as M25, Mutual Capital Partners, Refinery Ventures, Rev1 Ventures, North Coast Ventures, and Blue Heron Capital. This funding underscores their robust market potential and investor confidence.
Cosmos Rx